Steady On, Pharma
Pharma’s 2022 growth forecast has been reduced for the first time in a decade
EvaluatePharma have published their annual “World Preview,” which has – for the first time in the past 10 years – reduced pharma’s 2022 drug sales outlook. Last year pharma was forecasted to sell $1.12 trillion’s worth of pharmaceuticals in 2022; this year, the report estimates 2022 sales will total $1.06 trillion. The report stated, “This slight retraction is likely due to a number of factors, but the continuing squeeze on pricing is almost certainly a major one” (1). Here are a few key statistics taken from the report.
- EvaluatePharma, “World Preview 2017, Outlook to 2022”, (2017). Last accessed November 11, 2017. Available at: bit.ly/2wxzYtd.
My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.
